The charity Leukaemia Care today welcomes the news from the National Institute for Health and Care Excellence that a new cancer treatment drug asciminib has been approved for NHS use in chronic myeloid leukaemia (CML) patients after two or ...
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral implants, announced today the signing of an agreement defining the principles of a strategic, technological and financial ...
Regard (formerly known as HealthTensor), a software company developing an artificial intelligence (AI) co-pilot for physicians to help diagnose medical conditions, today announced it has raised $15.3 million in Series A funding. The financing was led by Calibrate Ventures and Foundry ...
Popular Posts
